Rosetta Inpharmatics' Acquisition

Rosetta Inpharmatics was acquired by Merck & Co. on May 12, 2001.

Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery.…

Articles about Rosetta Inpharmatics' Acquisition: